|
⚲
|
| Keyboard |
| Cabatuan Nelson
✚
|
|
|---|---|
| CIK # | 0001725908 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001725908] | |
| 4 | [0001725908] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Lexaria Corp | |
| Cabatuan Nelson | |
| Rain Oncology Inc | |
| Rigel Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Rain Oncology Inc RAIN
Stock Option (Right to Buy) · derivative
|
2023-02-15 | Grant | 65,325 | $0.00 | |
|
Rain Oncology Inc RAIN
Stock Option (Right to Buy) · derivative
|
2022-01-07 | Grant | 32,000 | $0.00 | |
|
Rain Oncology Inc RAIN
Stock Option (Right to Buy) · derivative
|
2021-05-12 | Grant | 6,000 | $0.00 | |
|
Rigel Pharmaceuticals Inc RIGL
Stock Option (Right to Buy) · derivative
|
2020-05-14 | Grant | 20,000 | $0.00 | |
|
Rigel Pharmaceuticals Inc RIGL
Stock Option (right to buy) · derivative
|
2020-02-06 | Grant | 90,000 | $0.00 | |
|
Rigel Pharmaceuticals Inc RIGL
Employee Stock Option (right to buy) · derivative
|
2019-01-23 | Grant | 60,000 | $0.00 | |
|
Rigel Pharmaceuticals Inc RIGL
Common Stock
|
2018-10-12 | Sell | 10,000 | $3.12 | 31,200 |
|
Rigel Pharmaceuticals Inc RIGL
Employee Stock Option (Right to Buy) · derivative
|
2018-08-14 | Grant | 20,000 | $0.00 | |
|
Rigel Pharmaceuticals Inc RIGL
Employee Stock Option (right to buy) · derivative
|
2018-01-24 | Grant | 24,000 | $0.00 |